Relationship between CCR and NT-proBNP in Chinese HF Patients, and Their Correlations with Severity of HF

Table 2

Paired comparison for biology markers between control group and heart failure group.

Variable	NYHA		SE	value	95% CI
					Lower	Upper
Male	0	2	0.07	0.32	−0.21	0.07
		3	0.06	0.01	−0.29	−0.04
	2	3	0.07	0.18	−2.24	0.05
Hypertension	0	2	0.07	0.00	−0.39	−0.13
		3	0.06	0.00	−0.33	−0.10
	2	3	0.07	0.49	−0.09	0.18
Diabetes	0	2	0.06	0.02	−0.26	−0.02
		3	0.05	0.00	−0.33	−0.11
	2	3	0.06	0.20	−0.21	0.04
NT-proBNP	0	2	153.31	0.00	−1834.29	−1231.12
		3	135.20	0.00	−3349.31	−2817.41
	2	3	156.30	0.00	−1858.11	−1243.20
CCR	0	2	2.49	0.00	25.62	35.40
		3	2.19	0.00	32.06	40.69
	2	3	2.53	0.02	0.88	10.85
Cr	0	2	0.03	0.00	−0.46	−0.35
		3	0.04	0.00	−0.54	−0.44
	2	3	0.03	0.01	−0.14	−0.02
UA	0	2	14.99	0.00	−149.18	−90.20
		3	13.22	0.00	−198.33	−146.31
	2	3	15.30	0.00	−82.70	−22.56
LVEDD	0	2	0.94	0.00	−7.52	−3.82
		3	0.83	0.00	−9.27	−6.01
	2	3	0.96	0.04	−3.85	−2.76

CCR: creatinine clearance rate; CI: confidence interval; Cr: creatinine; LVEDD: left ventricular end-diastolic diameter; NT-proBNP: N-terminal pro-B-type natriuretic peptide; NYHA: New York Heart Association; SE: standard error; UA: uric acid.